11462
E. Saniger et al. / Tetrahedron 60 (2004) 11453–11464
4.3. Synthesis of (RS)-2-methoxy-2,3-dihydro-5H-1,4-
benzodioxepins 2a,d,e and (RS)-5-methoxy-2,3,5,6-
tetrahydro-8H-benzo-[1,4,7]-trioxecin 5a,d,e
HR LSIMS calcd for C10H11O3NaCl (MCNa)C 237.0294,
found 237.0299. Anal. for C10H11O3Cl: Calcd: C 55.96; H
5.17. Found: C 56.22; H 4.87.
The general procedure is exemplified with the case of 2a
and 5a: 9a (1.5 g, 4.9 mmol) was dissolved in anhydrous
THF (15 mL), and BF3$OEt2 (0.3 mL) was added at 0 8C
and the mixture was kept at this temperature under stirring
for 24 h. After this time the solution was washed with an
aqueous solution of K2CO3 (10%) and extracted with
CH2Cl2. The organic layer was dried (Na2SO4), filtered, and
concentrated. The residue was purified by flash chromato-
graphy with diethyl ether/hexane (1/3) yielding 0.36 g of 3a
(41%), and 0.12 g of 5a (6%). After concentrating the
organic layer, the residue was subjected to a simple
combination of directly-coupled gas chromatography-mass
spectrometry (GC-MS): tR of methoxymethanol: 4.14 min;
tR of methoxymethoxyethanol: 6.76 min. The identity of
methoxymethanol14 and methoxymethoxyethanol15 were
confirmed by comparison of their retention times with pure
authentic samples.
Compound 5d. Yield: 22%. Rf (ethyl acetate/hexane: 4/1):
0.6. H NMR (400 MHz) d 7.23 (dd, 1H, H-11, JZ2.5,
1
8.4 Hz); 7.15 (d, 1H, H-9, JZ2.5 Hz); 7.05 (d, 1H, H-12,
JZ8.4 Hz); 4.8 (dd, 1H, H-5, JZ1.6, 6.6 Hz); 4.59 (dd, 2H,
H-8, JZ1.2, 13.6 Hz); 4.11 (m, 2H, H-6, H-2); 3.8 (m, 2H,
H-6, H-2); 3.6 (m, 2H, H-3, H-3); 3.39 (s, 3H, OMe). 13C
NMR (100 MHz) d 153.00 (C-13); 134.97 (C-10); 129.22
(C-11); 128.92 (C-9); 128.85 (C-14); 122.87 (C-12); 103.18
(C-5); 74.91 (C-6); 72.22 (C-2); 71.54 (C-8); 68.20 (C-3);
59.15 (OMe). HR LSIMS calcd for C12H15O4NaCl (MC
Na)C 281.0556, found 281.0563. Anal. for C12H15O4Cl:
Calcd: C 55.71; H 5.84. Found: C 55.83; H 6.03.
4.3.2. (RS)-7-Bromo-2-methoxy-2,3-dihydro-5H-1,4-
benzodioxepin 3e and (RS)-10-bromo-5-methoxy-
2,3,5,6-tetrahydro-8H-benzo-[1,4,7]-trioxecin 5e. Com-
pound 9e was used as a starting material. 3e: Yield: 27%. Rf
(diethyl ether/hexane: 2/1): 0.6. 1H NMR (400 MHz) d 7.35
(dd, 1H, H-8, JZ2.4, 8.4 Hz); 7.27 (d, 1H, H-6, JZ2.4 Hz);
6.99 (d, 1H, H-9, JZ8.4 Hz); 4.65 (dd, 1H, H-2, JZ1.6,
6.1 Hz); 4.57 (d, 2H, H-5, JZ2.1 Hz); 4.00 (dd, 1H, H-3,
JZ1.6, 12.6 Hz); 3.76 (dd, 1H, H-3, JZ6.1, 12.6 Hz); 3.56
(s, 3H, OMe). 13C NMR (100 MHz) d 153.45 (C-10); 135.27
(C-11); 132.25 (C-8); 131.76 (C-6); 123.32 (C-9); 116.46
(C-7); 104.04 (C-2); 74.85 (C-3); 72.32 (C-5); 56.63 (OMe).
HR LSIMS calcd for C10H12O3Br (MCC1) 258.9969,
found 258.9976. Anal. for C10H11O3Br: Calcd: C 46.36; H
4.28. Found: C 45.97; H 4.11.
Compound 3a. Rf (diethyl ether/hexane: 2/1): 0.61. 1H NMR
(300 MHz) d 7.31 (dt, 1H, HAr, JZ1.7, 7.7 Hz); 7.20 (dd,
1H, HAr, JZ1.7, 7.7 Hz); 7.17 (dd, 1H, HAr, JZ1.3,
7.7 Hz); 7.09 (dt, 1H, HAr, JZ1.3, 7.7 Hz); 4.70 (dd, 1H,
H-2, JZ1.6, 6.3 Hz); 4.68 (d, 2H, H-5, 1.6); 4.07 (dd,
1H, H-3, JZ1.6, 12.5 Hz); 3.81 (dd, 1H, H-3, JZ6.3,
12.5 Hz); 3.62 (s, 3H, OMe). 13C NMR (75 MHz) d
154.30 (C-10); 133.26 (C-11); 129.49, 129.04 (C-6 and
C-8); 124.00 (C-9); 121.48 (C-7); 103.99 (C-2); 74.86
(C-3); 72.87 (C-5); 56.50 (OMe). HR LSIMS calcd for
C10H12O3Na (MCNa)C 203.0694, found 203.0683.
Anal. for C10H12O3: Calcd: C 66.65; H 6.71. Found: C
66.19; H 6.85.
Compound 5e. Yield: 18%. Rf (diethyl ether/hexane: 2/1):
1
0.46. H NMR (400 MHz) d 7.34 (dd, 1H, H-11, JZ2.4,
8.4 Hz); 7.26 (d, 1H, H-9, JZ2.4 Hz); 6.97 (d, 1H, H-12,
JZ8.4 Hz); 4.77 (dd, 1H, H-5, JZ1.7, 6.6 Hz); 4.56 (dd,
2H, H-8, JZ1.5, 14.1 Hz); 4.07 (m, 2H, H-6, H-2); 3.76 (m,
2H, H-6, H-2); 3.56 (m, 2H, H-3, H-3); 3.35 (s, 3H, OMe).
13C NMR (100 MHz) d 153.60 (C-13); 135.45 (C-10);
132.28 (C-11); 131.82 (C-9); 123.35 (C-12); 116.53 (C-14);
103.22 (C-5); 74.92 (C-6); 72.19 (C-2); 71.61 (C-8); 68.25
(C-3); 59.17 (OMe). HR LSIMS calcd for C12H15O4NaBr
(MCNa)C 325.0051, found 325.0053. Anal. for
C12H15O4Br: Calcd: C 47.54; H 4.99. Found: C 47.81; H
5.13.
Compound 5a. Rf (diethyl ether/hexane: 4/1): 0.39. 1H NMR
(400 MHz) d 7.29 (dt, 1H, H-11 or H-10, JZ1.7, 7.8 Hz);
7.17 (dd, 1H, H-9 or H-12, JZ1.7, 7.4 Hz); 7.13 (dd, 1H,
H-12 or H-9, JZ1.1, 7.8 Hz); 7.07 (dt, 1H, H-10 or
H-11, JZ1.1, 7.4 Hz); 4.81 (dd, 1H, H-5, JZ1.7, 6.8 Hz);
4.65 (dd, 2H, H-8, JZ2.6, 13.3 Hz); 4.14 (m, 2H, H-6, H-2);
3.81 (m, 2H, H-6, H-2); 3.61 (m, 2H, H-3, H-3); 3.39 (s, 3H,
OMe). 13C NMR (100 MHz) d 154.44 (C-13); 133.43
(C-14); 129.52 (C-11); 129.05 (C-9); 124.05 (C-10); 121.40
(C-12); 103.16 (C-5); 74.91 (C-6); 72.72 (C-2); 71.58 (C-8);
68.08 (C-3); 59.12 (OMe). HR LSIMS calcd for
C12H16O4Na (MCNa)C 247.0946, found 247.0945. Anal.
for C12H16O4$0.1H2O: Calcd: C 64.27; H 7.19. Found: C
64.00; H 7.20.
4.4. Synthesis of 2-(methoxyethoxymethoxymethyl)-
phenyloxyacetaldehyde dimethyl acetals 11b and 11c
The procedure was similar to the one used in 4.3, but
changing 9a by 10b, and 9a by 10c.
4.3.1. (RS)-7-Chloro-2-methoxy-2,3-dihydro-5H-1,4-
benzodioxepin 3d and (RS)-10-chloro-5-methoxy-
2,3,5,6-tetrahydro-8H-benzo-[1,4,7]-trioxecin 5d. Com-
pound 9d was used as a starting material. 3d: Yield: 45%. Rf
(ethyl acetate/hexane: 4/1): 0.7. 1H NMR (400 MHz) d 7.23
(dd, 1H, H-8, JZ2.5, 8.4 Hz); 7.15 (d, 1H, H-6, JZ2.5 Hz);
7.07 (d, 1H, H-9, JZ8.4 Hz); 4.68 (dd, 1H, H-2, JZ1.5,
6.0 Hz); 4.60 (d, 2H, H-5, JZ1.7 Hz); 4.03 (dd, 1H, H-3,
JZ1.5, 12.6 Hz); 3.80 (dd, 1H, H-3, JZ6.0, 12.6 Hz); 3.59
(s, 3H, OMe). 13C NMR (100 MHz) d 152.85 (C-10); 134.80
(C-11); 134.79 (C-7); 129.20 (C-8); 128.83 (C-6); 122.94
(C-9); 103.99 (C-2); 74.85 (C-3); 72.37 (C-5); 56.61 (OMe).
4.4.1. [4-Methoxy-2-(methoxyethoxymethoxymethyl)]-
phenyloxyacetaldehyde dimethyl acetal 11b. Compound
10b was used as starting material. Yield: 26%. Rf (ethyl
1
acetate/hexane: 2/1): 0.4. H NMR (300 MHz) d 6.95 (d,
1H, H-3, JZ2.8 Hz); 6.76 (t, 1H, H-6, JZ8.8 Hz); 6.73 (dd,
1H, H-5, JZ2.8, 8.8 Hz); 4.82 (s, 2H, OCH2O); 4.66 (t, 1H,
H-10, JZ5.2 Hz); 4.63 (s, 2H, C-2-CH2O); 3.94 (d, 2H,
H-20, JZ5.2 Hz); 3.73 (s, 1H, C-4-OMe); 3.73 (m, 2H, AA0
part of the ethylenedioxy fragment); 3.54 (m, 2H, BB0 part
of the ethylenedioxy fragment); 3.41 (s, 6H, (OMe)2); 3.37